Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.

Carril-Ajuria, Lucil; Remolina-Bonilla, Yuly A; Carretero-Gonzalez, Alberto; Martin-Soberon, Maricruz; Castellano, Daniel; Bourlon, Christianne; de Velasco, Guillermo; Bourlon, Maria T

Carril-Ajuria, Lucil; Remolina-Bonilla, Yuly A; Carretero-Gonzalez, Alberto; Martin-Soberon, Maricruz; Castellano, Daniel; Bourlon, Christianne; de Velasco, Guillermo; Bourlon, Maria T.

Carril-Ajuria L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Remolina-Bonilla YA; Department of Hematology and Oncology, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Carretero-Gonzalez A; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Martin-Soberon M; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Bourlon C; Department of Hematology and Oncology, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
de Velasco G; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Bourlon MT; Department of Hematology and Oncology, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Oncology (Williston Park) ; 34(8): 317-319, 2020 08 12.

Article in English | MEDLINE | ID: covidwho-713075

ABSTRACT

ABSTRACT

A 78-year-old man had a medical history of hypertension, atrial fibrillation, chronic kidney disease, and metastatic castration-resistant prostate cancer (CRPC). He had progressed to first-line therapy for CRPC with abiraterone plus androgen-deprivation therapy (ADT) and as second-line therapy he was being treated with docetaxel, with biochemical progression in his last prostate specific antigen measurement. He was admitted to the hospital on April 2020, in the middle of the coronavirus disease 2019 (COVID-19) pandemic, because of painful bone lesions and deterioration of renal function.

Subject(s)

Anticoagulants/therapeutic use; Bone Neoplasms/drug therapy; Coronavirus Infections/therapy; Palliative Care; Pneumonia, Viral/therapy; Prostatic Neoplasms, Castration-Resistant/drug therapy; Respiratory Insufficiency/therapy; Aged; Androgen Antagonists/therapeutic use; Androstenes/therapeutic use; Antineoplastic Agents/therapeutic use; Betacoronavirus; Bone Density Conservation Agents/therapeutic use; Bone Neoplasms/complications; Bone Neoplasms/secondary; COVID-19; Cancer Pain/complications; Cancer Pain/therapy; Coronavirus Infections/complications; Disease Progression; Docetaxel/therapeutic use; Drug Combinations; Eligibility Determination; Heparin, Low-Molecular-Weight/therapeutic use; Humans; Intensive Care Units/supply & distribution; Lopinavir/therapeutic use; Male; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral/complications; Prostatic Neoplasms, Castration-Resistant/complications; Prostatic Neoplasms, Castration-Resistant/pathology; Renal Insufficiency; Respiratory Insufficiency/etiology; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir/therapeutic use; SARS-CoV-2; Severity of Illness Index; Zoledronic Acid/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Palliative Care / Pneumonia, Viral / Respiratory Insufficiency / Bone Neoplasms / Coronavirus Infections / Prostatic Neoplasms, Castration-Resistant / Anticoagulants Type of study: Case report / Prognostic study Topics: Long Covid Language: English Journal: Oncology (Williston Park) Journal subject: Neoplasms Year: 2020 Document Type: Article Affiliation country: ONC.2020.3408.0317

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google